Report Code: CMI50445

Published Date: June 2024

Pages: 320+

Category: USA

Reports Description

US Cell Separation Market was valued at USD 3.8 Billion in 2024 and is expected to reach USD 7.8 Billion by 2033, at a CAGR of 6.3% during the forecast period 2024 – 2033.

Cell separation, also known as cell sorting or cell isolation, is a process used to separate specific cell populations from a heterogeneous mixture. This technique is crucial in various fields such as biotechnology, medicine, and research.

US Cell Separation Market: Growth Factors

Growing focus on personalized medicine

The growing focus on personalized medicine in the United States is driving significant expansion in the cell separation market. Personalized medicine aims to tailor medical treatment to individual characteristics, including genetic makeup, lifestyle, and environment.

This approach requires precise identification and isolation of specific cell types for various therapeutic and diagnostic purposes. Cell separation technologies play a pivotal role in this process by enabling the isolation of target cells from heterogeneous samples such as blood, tissue, or bone marrow.

These isolated cells can then be used for a range of applications, including cell-based therapies, cancer diagnostics, and research into disease mechanisms. Advancements in cell separation techniques, such as flow cytometry, magnetic-activated cell sorting (MACS), and microfluidic-based technologies, offer high specificity, efficiency, and scalability, making them increasingly attractive for personalized medicine applications.

As the demand for tailored treatments continues to rise and technologies for precise cell isolation become more sophisticated, the US cell separation market is poised for substantial growth, driven by the need to unlock the full potential of personalized medicine in improving patient outcomes and healthcare efficiency.

Increasing investments in cell biology research

Increasing investments in cell biology research are propelling growth in the US cell separation market. As funding streams expand, researchers are empowered to delve deeper into understanding cellular mechanisms and developing advanced therapies.

This surge in investment is particularly evident in areas such as regenerative medicine, immunotherapy, and personalized medicine, where precise cell separation techniques are essential for isolating specific cell populations. Consequently, there’s a growing demand for innovative cell separation technologies capable of isolating cells with high purity and yield, driving market expansion.

Moreover, with the rising prevalence of chronic diseases and the urgent need for effective treatments, there’s a heightened focus on developing novel cell-based therapies. These therapies often rely on the isolation and manipulation of therapeutic cells, driving further demand for sophisticated cell separation tools.

Additionally, advancements in biotechnology and automation are enhancing the efficiency and scalability of cell separation processes, further fuelling market growth.

As a result, the US cell separation market is witnessing robust expansion, driven by the convergence of increased research funding, technological advancements, and the burgeoning demand for cell-based therapies across various medical fields.

US Cell Separation Market: Restraints

High cost

The high cost associated with cell separation technologies presents a significant barrier to entry and expansion in the US market. Cell separation techniques, crucial in various biomedical applications including research, diagnostics, and therapeutics, require sophisticated equipment and consumables, leading to elevated production and operational costs.

These expenses often result in higher prices for end-users, limiting accessibility to smaller research labs and institutions with constrained budgets. Moreover, the upfront investment required for implementing these technologies dissuades many potential buyers, particularly smaller enterprises or startups, from entering the market or scaling up their operations.

The high cost of cell separation technologies not only affects their adoption but also hinders innovation and technological advancement within the field. Companies are often compelled to prioritize cost efficiency over research and development, potentially slowing down progress in improving cell separation methods and expanding their applications.

Additionally, the financial burden imposed by expensive equipment and consumables reduces the competitiveness of US companies in the global market, where lower-cost alternatives may emerge from regions with cheaper production or regulatory environments.

As a result, despite the promising potential of cell separation technologies in revolutionizing various industries, their widespread adoption and market growth in the US are hampered by the significant economic barriers they pose.

US Cell Separation Market: Opportunities

Adoption of advanced equipment

The adoption of advanced equipment within the US cell separation market has catalysed significant advancements in biotechnology and medical research. Advanced technologies such as flow cytometry, magnetic-activated cell sorting (MACS), and microfluidics have revolutionized the process of isolating and purifying specific cell populations with unprecedented precision and efficiency.

Flow cytometry, for instance, enables high-throughput analysis and sorting of cells based on multiple parameters such as size, granularity, and surface markers, facilitating the study of complex cell populations and the identification of rare cell types.

Similarly, MACS utilizes magnetic nanoparticles conjugated to antibodies to selectively label and isolate target cells, offering a rapid and gentle method for cell separation without the need for extensive sample manipulation.

Furthermore, microfluidic platforms leverage miniaturized channels and precise control of fluid flow to achieve highly efficient cell separation at a microscale level, enabling applications in point-of-care diagnostics and personalized medicine.

The integration of these advanced technologies not only enhances research capabilities in fields such as immunology, oncology, and regenerative medicine but also drives innovation in clinical diagnostics and therapeutic development, thereby propelling the growth of the US cell separation market and its contributions to advancing healthcare outcomes.

US Cell Separation Market: Segmentation Analysis

The US Cell Separation market is segmented by product, technology and application.  Based on product, the market is classified into consumables and instruments. Consumables dominated the market in 2023 with a market share of 60.2% and are expected to keep their dominance during the forecast period 2024-2033.

Consumables play a pivotal role in propelling the US cell separation market forward, acting as the indispensable components that enable the isolation of specific cell populations for various applications. These consumables encompass a wide array of products, including reagents, kits, and disposable instruments, all designed to streamline and optimize the cell separation process.

With the burgeoning demand for advanced therapies, diagnostics, and research endeavors reliant on precise cell isolation, the market for consumables experiences steady growth.

Moreover, the adoption of automated and high-throughput cell separation systems further amplifies the need for consumables, as these systems require specialized reagents and disposables tailored to their functionalities.

The competitive landscape is characterized by the presence of established players continually innovating to introduce novel consumables with enhanced performance, purity, and ease of use. Additionally, collaborations between academia, industry, and research institutes foster the development of customized consumables catering to specific research requirements.

As a result, consumables emerge as the cornerstone of the US cell separation market, driving innovation, efficiency, and growth in the broader landscape of cellular research, diagnostics, and therapeutic applications.

Based on technology, the market is classified into centrifugation, surface marker and filtration. Centrifugation dominated the market in 2023 with a market share of 44.1% and is expected to keep its dominance during the forecast period 2024-2033.

Centrifugation has been a transformative force in propelling the US cell separation market forward due to its unparalleled efficiency and versatility in isolating various types of cells from complex mixtures. By subjecting heterogeneous cell suspensions to high-speed rotational forces, centrifugation exploits differences in cell size, density, and buoyancy to separate them into distinct fractions.

In biotechnology and biopharmaceutical settings, centrifugation plays a pivotal role in the isolation of target cells for therapeutic purposes, such as stem cell therapies and immunotherapy. Its ability to precisely separate cells based on their physical properties enables researchers to obtain high-purity cell populations, essential for downstream analyses and applications.

Moreover, centrifugation-based cell separation techniques have significantly advanced research efforts in fields like cancer biology, neuroscience, and regenerative medicine by facilitating the isolation of specific cell types from complex tissues or blood samples.

The continuous innovation in centrifugation technologies, coupled with the growing demand for advanced cell isolation methods, is expected to further drive the expansion of the US cell separation market, fostering breakthroughs in both basic research and clinical applications.

Based on application, the market is classified into Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies and Others. Biotechnology and Biopharmaceutical Companies dominated the market in 2023 with a market share of 66.1% and are expected to keep their dominance during the forecast period 2024-2033.

Biotechnology and biopharmaceutical companies play a pivotal role in driving the US cell separation market through innovative research, development, and commercialization of advanced cell separation technologies. These companies invest heavily in R&D to create cutting-edge tools and techniques for isolating specific cell types from complex mixtures, such as blood or tissue samples.

By leveraging biotechnological advancements, they enhance the efficiency, accuracy, and scalability of cell separation processes, meeting the increasing demand for high-quality cells in various applications including cell therapy, regenerative medicine, drug discovery, and diagnostics.

Furthermore, biopharmaceutical companies utilize cell separation technologies to streamline the production of biologics such as monoclonal antibodies, recombinant proteins, and cell-based therapies, optimizing manufacturing processes and improving product yields.

Their expertise in molecular biology, immunology, and bioengineering enables them to develop custom solutions tailored to specific research and clinical needs, driving the adoption of cell separation technologies across academia, healthcare institutions, and biotechnology sectors.

Through strategic partnerships, collaborations, and licensing agreements, these companies facilitate the transfer of innovative technologies from the laboratory to the market, fostering growth and innovation in the US cell separation market while advancing scientific discovery and improving patient outcomes.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 3.8 Billion
Projected Market Size in 2033 USD 7.8 Billion
Market Size in 2023 USD 3.4 Billion
CAGR Growth Rate 6.3% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Product, Technology, Application and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Country Scope US
Buying Options Request tailored purchasing options to fulfil your requirements for research.

US Cell Separation Market: Recent Developments

  • In May 2023, BD announced the commercial introduction of a new cell sorting tool that combined two ground-breaking technological advancements that allowed researchers to see data concerning cells that had been concealed in conventional flow cytometry tests.
  • In May 2023, Akadeum Life Sciences announced the launch of T-cell activation/expansion and Leukopak human immune cell isolation kits for cell therapy R&D. With the help of this launch, the company planned to strengthen their Leukopak cell isolation product lines.
  • In February 2021, Propel Labs, established in the US, sold its cell-sorting assets to Thermo Fisher Scientific. According to the agreement, Propel Labs’ innovative Bigfoot Spectral Cell Sorter and about 40 personnel were added to Thermo Fisher Scientific’s capabilities.

List of the prominent players in the US Cell Separation Market:

  • Thermo Fisher Scientific Inc.
  • BD
  • Danaher
  • Terumo Corp.
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Agilent Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences
  • Others

These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.

The US Cell Separation Market is segmented as follows:

By Product

  • Consumables
  • Instruments
  • Others

By Technology

  • Centrifugation
  • Surface Marker
  • Filtration

By Application

  • Research Laboratories and Institutes
  • Biotechnology and Biopharmaceutical Companies
  • Others

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1 US Cell Separation Market, (2024 – 2033) (USD Billion)
    • 2.2 US Cell Separation Market: snapshot
  • Chapter 3. US Cell Separation Market – Industry Analysis
    • 3.1 US Cell Separation Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growing focus on personalized medicine
      • 3.2.2 Increasing investments in cell biology research
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market Attractiveness Analysis By Product
      • 3.7.2 Market Attractiveness Analysis By Technology
      • 3.7.3 Market Attractiveness Analysis By Application
  • Chapter 4. US Cell Separation Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 US Cell Separation Market: company market share, 2023
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaboration, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. US Cell Separation Market – Product Analysis
    • 5.1 US Cell Separation Market Overview: By Product
      • 5.1.1 US Cell Separation Market Share, By Product, 2023 and 2033
    • 5.2 Consumables
      • 5.2.1 US Cell Separation Market by Consumables, 2024 – 2033 (USD Billion)
    • 5.3 Instruments
      • 5.3.1 US Cell Separation Market by Instruments, 2024 – 2033 (USD Billion)
    • 5.4 Others
      • 5.4.1 US Cell Separation Market by Others, 2024 – 2033 (USD Billion)
  • Chapter 6. US Cell Separation Market – Technology Analysis
    • 6.1 US Cell Separation Market Overview: By Technology
      • 6.1.1 US Cell Separation Market Share, By Technology, 2023 and 2033
    • 6.2 Centrifugation
      • 6.2.1 US Cell Separation Market by Centrifugation, 2024 – 2033 (USD Billion)
    • 6.3 Surface Marker
      • 6.3.1 US Cell Separation Market by Surface Marker, 2024 – 2033 (USD Billion)
    • 6.4 Filtration
      • 6.4.1 US Cell Separation Market by Filtration, 2024 – 2033 (USD Billion)
  • Chapter 7. US Cell Separation Market – Application Analysis
    • 7.1 US Cell Separation Market Overview: By Application
      • 7.1.1 US Cell Separation Market Share, By Application, 2023 and 2033
    • 7.2 Research Laboratories and Institutes
      • 7.2.1 US Cell Separation Market by Research Laboratories and Institutes, 2024 – 2033 (USD Billion)
    • 7.3 Biotechnology and Biopharmaceutical Companies
      • 7.3.1 US Cell Separation Market by Biotechnology and Biopharmaceutical Companies, 2024 – 2033 (USD Billion)
    • 7.4 Others
      • 7.4.1 US Cell Separation Market by Others, 2024 – 2033 (USD Billion)
  • Chapter 8. US Cell Separation Market – Regional Analysis
    • 8.1 US Cell Separation Market Regional Overview
    • 8.2 US Cell Separation Market Share, by Region, 2023 & 2033 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1 Thermo Fisher Scientific Inc.
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 BD
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Danaher
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Terumo Corp.
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 STEMCELL Technologies Inc.
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 Bio-Rad Laboratories Inc.
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 Merck KGaA
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Agilent Technologies Inc.
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Corning Inc.
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 Akadeum Life Sciences
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments
    • 9.11 Others.
      • 9.11.1 Overview
      • 9.11.2 Financials
      • 9.11.3 Product Portfolio
      • 9.11.4 Business Strategy
      • 9.11.5 Recent Developments
List Of Figures

Figures No 1 to 20

List Of Tables

Tables No 1 to 2

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2033

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers

Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2033
  • Market revenue estimates and forecasts up to 2033, by technology
  • Market revenue estimates and forecasts up to 2033, by application
  • Market revenue estimates and forecasts up to 2033, by type
  • Market revenue estimates and forecasts up to 2033, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • Thermo Fisher Scientific Inc.
  • BD
  • Danaher
  • Terumo Corp.
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Agilent Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences
  • Others


The restraints of the US Cell Separation market is high cost.

The major driver for the US Cell Separation market is growing focus on personalized medicine and increasing investments in cell biology research.

The “Research Laboratories and Institutes” had the largest share in the market for US Cell Separation.

The “Consumables” category dominated the market in 2023.

The key players in the market are Thermo Fisher Scientific Inc., BD, Danaher, Terumo Corp., STEMCELL Technologies Inc., Bio-Rad Laboratories Inc., Merck KGaA, Agilent Technologies Inc., Corning Inc., Akadeum Life Sciences, Others.

The market is projected to grow at a CAGR of 6.3% during the forecast period, 2024-2033.

The US Cell Separation Market size was valued at USD 3.8 Billion in 2024.












What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • Report in your Language.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Report in your Language.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • In-Depth Company Profiles.
  • SWOT Analysis.
  • Identify your Competitors.
  • Recent Development Analysis.
  • Competitor Pricing Strategies.
  • Competitor Marketing Strategies.
  • Competitor Positioning and Messaging.
  • Competitor Product’s Strengths.
  • Free 20% or 10 Hours of Customisation.
  • 15% Discount on your Next Purchase.
  • Upgradable to other licenses.
  • PDF Format.
  • Permission to Print the Report.

Want to customize this report?